November 28, 2012 Viratech Corp (OTC:VIRA) and Newswire are proud to announce a new joint project called “This Week in Viratech”. Viratech and Newswire have a signed an agreement to collaborate on the exciting new promotion and education project. “This Week in Viratech” is a 26 episode project airing every Saturday morning on a YouTube channel at http://www.youtube.com/user/ViratechNews . The purpose of the program is to announce what has happened in the past week at Viratech Corp as Viratech moves out of the research and development phase of their new open source biotech research social network platform and into business development and revenue stages.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology. Using videos and other visuals, “This Week in Viratech” will explain to the lay community how its business model works in its three key phases: Protect, Promote and Produce. “This Week in Viratech” will also provide a question and answer format for viewers to explore more about the business model and how it works.
Under “Protect”, the business model shows how to protect intellectual property while the patent is pending by the use of copyright and the creation of a copyright shell. “Promote” details how a micro social network, or MSN, is used to promote segments of the patent pending idea to attract research, knowledge and funding partners as members of the MSN. Once formed, the MSN is then used to “Produce” the product through crowdfunding and Viratech’s innovative approach to compensating members for their micro social network activity.
Viratech Corp’s model opens the playing field up to developers on all resource levels and turns the biotech industry into an open source arena welcoming innovation and providing avenues for those innovations to be realized. Through the collaboration agreement with Newswire, “This Week in Viratech” shares the vision with both the general public and those small business researchers and developers anxious to protect their intellectual property while actively working to make it a reality. Viratech Corp and Newswire believe this open source platform will change the landscape of intellectual property and finally allow medicine to make advancements on a similar scale to communication technology.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Email Contact: email@example.com
To learn more abour viratech, please send an emial at firstname.lastname@example.org